Artedrone is trying to raise a €20 million Series B funding round to finalize its preclinical work and fund the ...

Artedrone is developing a microrobot system that can navigate to blood clots for autonomous mechanical thrombectomies.

The global human liver model market was valued at USD 1.19 billion in 2023 and is projected to expand at a robust CAGR of 13.8% from 2024 to 2030, culminating in a market size of USD 3.19 billion by ...

The White House released an expansive report that blames a crisis of chronic disease in children on ultraprocessed foods, chemical exposures, lack of physical activity, stress and excessive use of ...

Q4 2025 Earnings Call Transcript May 15, 2025 Doximity, Inc. beats earnings expectations. Reported EPS is $0.38, expectations ...

Four medical affairs leaders reveal what’s working (and what’s not) when it comes to engaging time-starved HCPs in 2025.

OXURION - Oxurion announces the signing of a binding agreement to acquire French biometrics specialist Axiodis CRO ...

Discover how ballistic gradients, vacuum jacketed columns, and advanced MS technology work together to boost lipidomic ...

Commercialization building with large pharma contracts secured Further progress on next generation sequencing assays for DNA ...

A new study highlights the potential of whole genome and transcriptome sequencing (WGTS) to improve precision treatment and ...

Exicure, Inc. (Nasdaq: XCUR), a clinical-stage biotechnology company developing therapeutics for hematologic diseases, today announced it has completed patient enrollment in its ongoing Phase 2 ...

Some health-data companies are selling access to patient records to pharmaceutical companies without patients’ knowledge, according to a new study. The paper found “complex reciprocal ...